Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Glucocorticoid Receptor Signaling in Skin Barrier Function

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Thyroid Hormone Receptors and their Role in Cell Proliferation and Cancer

  • Martínez-Iglesias, Olaia
  • Ruiz-Llorente, Lidia
  • Contreras-Jurado, Constanza
  • Aranda, Ana
The thyroid hormone receptors, TRα and TRβ, are ligand-dependent transcription factors that regulate gene expression by recruitment of coactivators and corepressors. These receptors play an important role in normal and malignant cell proliferation. TRs can antagonize ras-dependent proliferation, transformation, and tumorigenesis. Furthermore, expression of TRβ1 in cancer cells retards tumor growth and inhibits invasion, extravasation, lymphangiogenesis, and metastasis formation in euthyroid nude mice. The corepressor NCoR is required for these tumor-suppressor actions of the receptor. When cells are inoculated into hypothyroid hosts, tumor growth is retarded, but metastatic growth is enhanced. Increased malignancy of skin tumors is found in mice lacking TRs, further demonstrating the role of these receptors as inhibitors of tumor progression. TRs have a dual effect on proliferation because they are required for proliferation of normal hepatocytes or keratinocytes and activation and mobilization of skin stem cells while acting as inhibitors of tumor progression., The laboratory of Ana Aranda is supported by Grants SAF2017-83289-R and SAF2017-90604-REDT (Ministerio de Ciencias, Innovación y Universidades) and B2017/BMD-3724 (Comunidad de Madrid)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Wnt and vitamin D at the crossroads in solid cancer

  • González-Sancho, José Manuel
  • Larriba, María Jesús
  • Muñoz Terol, Alberto
Abnormal activation of the Wnt/β-catenin pathway is common in many types of solidcancers. Likewise, a large proportion of cancer patients have vitamin D deficiency. In line with these observations, Wnt/β-catenin signaling and 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), the active vitamin D metabolite, usually have opposite effects on cancer cell proliferation and phenotype. In recent years, an increasing number of studies performed in a variety of cancer types have revealed a complex crosstalk between Wnt/β-catenin signaling and 1,25(OH)2D3. Here we review the mechanisms by which 1,25(OH)2D3 inhibits Wnt/β-catenin signaling and, conversely, how the activated Wnt/β-catenin pathway may abrogate vitamin D action. The available data suggest that interaction between Wnt/β-catenin signaling and the vitamin D system is at the crossroads in solid cancers and may have therapeutic applications., The work in the authors’ laboratory is funded by the Agencia Estatal de Investigación (PID2019-104867RB-I00/AEI/10.13039/501100011033), the Agencia Estatal de Investigación—Fondo Europeo de Desarrollo Regional (SAF2016-76377-R, MINECO/AEI/FEDER, EU), the Ministerio de Economía y Competitividad (SAF2017-90604-REDT/NuRCaMeIn), and the Instituto de Salud Carlos III—Fondo Europeo de Desarrollo Regional (CIBERONC; CB16/12/00273)., Peer reviewed